Jiraporn Tocharus Selected Research

Jiraporn Tocharus Research Topics

Disease

14	Inflammation (Inflammations) 01/2022 - 05/2010
11	Brain Ischemia (Cerebral Ischemia) 11/2022 - 01/2017
8	Infarction (Infarctions) 02/2022 - 01/2017
7	Alzheimer Disease (Alzheimer's Disease) 04/2021 - 01/2016
6	Reperfusion Injury 11/2022 - 01/2017
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2022 - 01/2020
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 04/2014
5	Neuroblastoma 01/2021 - 01/2015
4	Cognitive Dysfunction 01/2022 - 01/2020
4	Atherosclerosis 08/2021 - 03/2016
3	Neuroinflammatory Diseases 01/2022 - 07/2015
3	Glioma (Gliomas) 01/2017 - 04/2014
2	Ischemia 11/2022 - 01/2020
2	Gliosis 01/2022 - 03/2020
2	Hypertension (High Blood Pressure) 01/2022 - 12/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2021 - 10/2016
2	Obesity 01/2021 - 07/2019
2	Ischemic Stroke 01/2021 - 01/2017
2	Insulin Resistance 07/2020 - 07/2019
2	Body Weight (Weight, Body) 05/2020 - 12/2019
2	Amyloid Plaque 01/2016 - 01/2015
2	Colonic Neoplasms (Colon Cancer) 12/2012 - 05/2012
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Vascular Remodeling 01/2022
1	Brain Injuries (Brain Injury) 01/2022
1	Necrosis 12/2021
1	Wounds and Injuries (Trauma) 12/2021
1	Brain Infarction 10/2021
1	Hyperlipidemias (Hyperlipidemia) 08/2021
1	Non-alcoholic Fatty Liver Disease 07/2020
1	Hypoxia (Hypoxemia) 05/2020
1	Cerebral Infarction 01/2020

Drug/Important Bio-Agent (IBA)

9	MelatoninIBA 01/2022 - 04/2014
8	AntioxidantsIBA 01/2022 - 07/2015
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 05/2010
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2005
5	hexahydrocurcuminIBA 01/2022 - 05/2012
5	Amyloid (Amyloid Fibrils)IBA 04/2021 - 01/2015
4	agomelatine (S20098)IBA 02/2022 - 01/2017
4	Neuroprotective AgentsIBA 01/2022 - 09/2018
4	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2017 - 04/2014
3	CollagenIBA 01/2022 - 09/2005
3	dihydrocapsaicinIBA 10/2021 - 01/2017
3	cyanidinIBA 09/2018 - 12/2014
2	morinIBA 02/2022 - 01/2020
2	Cholinergic Agents (Cholinergics)IBA 01/2022 - 04/2021
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2022 - 01/2017
2	CurcuminIBA 01/2022 - 06/2020
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2022 - 12/2019
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2021 - 01/2017
2	CytokinesIBA 12/2021 - 03/2020
2	Caspase 3 (Caspase-3)IBA 10/2021 - 01/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 04/2021 - 01/2020
2	Amyloid beta-PeptidesIBA 01/2021 - 07/2018
2	GlucocorticoidsIBA 12/2020 - 01/2020
2	nonivamideIBA 07/2020 - 07/2019
2	Evans Blue (Blue, Evans)FDA Link 06/2020 - 01/2017
2	Pharmaceutical PreparationsIBA 12/2019 - 04/2014
2	Peptides (Polypeptides)IBA 07/2018 - 01/2016
2	cyanidin-3-O-beta-glucopyranosideIBA 10/2016 - 03/2016
2	Angiotensin IIIBA 10/2016 - 03/2016
2	Atorvastatin (Lipitor)FDA Link 09/2016 - 03/2016
2	DiarylheptanoidsIBA 01/2016 - 09/2015
2	demethylcurcuminIBA 01/2016 - 01/2015
2	Fluorouracil (Carac)FDA LinkGeneric 12/2012 - 05/2012
1	HMGB1 Protein (HMG1)IBA 11/2022
1	CateninsIBA 02/2022
1	flavan-3-olIBA 01/2022
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2022
1	Aluminum ChlorideIBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	Advanced Glycation End ProductsIBA 01/2022
1	Malondialdehyde (Propanedial)IBA 01/2022
1	arginine methyl esterIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 12/2021
1	Interleukin-1 (Interleukin 1)IBA 12/2021
1	neferineIBA 12/2021
1	Nimodipine (Modus)FDA LinkGeneric 12/2021
1	CalciumIBA 12/2021
1	InflammasomesIBA 08/2021
1	oxidized low density lipoproteinIBA 08/2021
1	tau Proteins (tau Protein)IBA 04/2021
1	LipidsIBA 07/2020
1	Immunoglobulin G (IgG)IBA 06/2020
1	triphenyltetrazoliumIBA 05/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2020
1	Angiogenesis InhibitorsIBA 05/2020
1	Metalloproteases (Metalloproteinases)IBA 05/2020
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 05/2020
1	salicylhydroxamic acid (SHAM)IBA 05/2020
1	Angiopoietin-1IBA 05/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020
1	Interleukin-6 (Interleukin 6)IBA 03/2020
1	IntegrinsIBA 03/2020
1	NF-kappa B (NF-kB)IBA 03/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2020

Therapy/Procedure

3	Therapeutics 07/2019 - 04/2012